Abu Dhabi [UAE], May 15 (ANI/WAM): Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health - Abu Dhabi (DoH) has stated that the launch of Neuralink's UAE-PRIME clinical trial in Abu Dhabi - the first international site outside North America - marks a powerful moment for the future of health.
He made the statements following the recent announcement by Neuralink regarding the launch of their first clinical trial in the Middle East, UAE-PRIME, at Cleveland Clinic Abu Dhabi in partnership with DoH, adding: "In collaboration with Cleveland Clinic Abu Dhabi, we are proud to enable the safe and responsible advancement of brain-computer interface technology, offering renewed hope to individuals living with severe neurological conditions."
He noted that this partnership exemplifies "Abu Dhabi's commitment to innovation in health and life sciences - driving the acceleration of breakthrough technologies that are purposefully tested, ethically governed, and made accessible to patients around the world." (ANI/WAM)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor